柚皮素抗乳腺癌作用机制的研究进展(4)
[15] Middleton E J,Kandaswami C,Theoharides T C.The effects of plant flavonoids on mammalian cells:implications for inflammation, heart disease,and cancer[J].Pharmacol Rev,2000,52(4):673-751.
[16] Kris-Etherton P M,Hecker K D,Bonanome A,et al.Bioactive compounds in foods:their role in the prevention of cardiovascular disease and cancer[J].Am J Med,2002,113 Suppl 9B(9):71S-88S.
[17] Harmon A W,Patel Y M.Naringenin Inhibits Glucose Uptake in MCF-7 Breast Cancer Cells: A Mechanism for Impaired Cellular Proliferation[J].Breast Cancer Research & Treatment 2004,85(2):103-110.
[18] Nie Y C,Wu H,Li P B,et al.Naringin attenuates EGF-induced MUC5AC secretion in A549 cells by suppressing the cooperative activities of MAPKs-AP-1 and IKKs-IκB-NF-κB signaling pathways[J].Eur J Pharmacol,2012,690(1-3):207-213.
[19] Hatkevich T,Ramos J,Santos-Sanchez I,et al.A naringenin-tamoxifen combination impairs cell proliferation and survival of MCF-7 breast cancer cells[J].Experimental Cell Research,2014,327(2):331-339.
[20] Sandhu P S,Kumar R,Beg S,et al.Natural lipids enriched self-nano-emulsifying systems for effective co-delivery of tamoxifen and naringenin:Systematic approach for improved breast cancer therapeutics[J].Nanomedicine,2017,13(5):1703-1713.
[21] Kitagawa S. Inhibitory effects of polyphenols on p-glycoprotein-mediated transport[J].Biol Pharm Bull,2006,29(1):1-6.
[22] van Zanden J J,Wortelboer H M,Bijlsma S,et al.Quantitative structure activity relationship studies on the flavonoid mediated inhibition of multidrug resistance proteins 1 and 2[J].Biochem Pharmacol,2005,69(4):699-708.
[23] Zhang F Y,Du G J,Zhang L,et al.Naringenin Enhances the Anti-Tumor Effect of Doxorubicin Through Selectively Inhibiting the Activity of Multidrug Resistance-Associated Proteins but not P-glycoprotein[J].Pharmaceutical Research,2009,26(4):914-925.
(收稿日期:2017-12-05) (本文編辑:周亚杰), http://www.100md.com(李亚东 张远起 李建文)
[16] Kris-Etherton P M,Hecker K D,Bonanome A,et al.Bioactive compounds in foods:their role in the prevention of cardiovascular disease and cancer[J].Am J Med,2002,113 Suppl 9B(9):71S-88S.
[17] Harmon A W,Patel Y M.Naringenin Inhibits Glucose Uptake in MCF-7 Breast Cancer Cells: A Mechanism for Impaired Cellular Proliferation[J].Breast Cancer Research & Treatment 2004,85(2):103-110.
[18] Nie Y C,Wu H,Li P B,et al.Naringin attenuates EGF-induced MUC5AC secretion in A549 cells by suppressing the cooperative activities of MAPKs-AP-1 and IKKs-IκB-NF-κB signaling pathways[J].Eur J Pharmacol,2012,690(1-3):207-213.
[19] Hatkevich T,Ramos J,Santos-Sanchez I,et al.A naringenin-tamoxifen combination impairs cell proliferation and survival of MCF-7 breast cancer cells[J].Experimental Cell Research,2014,327(2):331-339.
[20] Sandhu P S,Kumar R,Beg S,et al.Natural lipids enriched self-nano-emulsifying systems for effective co-delivery of tamoxifen and naringenin:Systematic approach for improved breast cancer therapeutics[J].Nanomedicine,2017,13(5):1703-1713.
[21] Kitagawa S. Inhibitory effects of polyphenols on p-glycoprotein-mediated transport[J].Biol Pharm Bull,2006,29(1):1-6.
[22] van Zanden J J,Wortelboer H M,Bijlsma S,et al.Quantitative structure activity relationship studies on the flavonoid mediated inhibition of multidrug resistance proteins 1 and 2[J].Biochem Pharmacol,2005,69(4):699-708.
[23] Zhang F Y,Du G J,Zhang L,et al.Naringenin Enhances the Anti-Tumor Effect of Doxorubicin Through Selectively Inhibiting the Activity of Multidrug Resistance-Associated Proteins but not P-glycoprotein[J].Pharmaceutical Research,2009,26(4):914-925.
(收稿日期:2017-12-05) (本文編辑:周亚杰), http://www.100md.com(李亚东 张远起 李建文)
参见:首页 > 医疗版 > 疾病专题 > 普通外科 > 乳腺癌